This inventor holds 7 USPTO granted patents and 9 published patent applications. Top assignees: Genzyme Corporation, Sionna Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 825 
2 out of 2 Years Active: 2026
Title: Gregory Hurlbut: Innovator in Pharmaceutical Compounds
Introduction
Gregory Hurlbut is an inventor based in Boxborough, MA (US). He is focused on developing innovative pharmaceutical compounds aimed at treating diseases related to deficient CFTR activity, particularly cystic fibrosis. Although he currently holds no granted patents, his work in this field is noteworthy.
Latest Patent Applications
Hurlbut's latest patent applications include "COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF." This application discusses heterocyclic compounds, their pharmaceutically acceptable salts, and pharmaceutical preparations. It also details compositions and the use of these compounds in methods for treating diseases mediated by deficient CFTR activity. Another significant application is "INDOLE COMPOUNDS AND METHODS OF USE," which similarly focuses on heterocyclic compounds and their applications in treating cystic fibrosis.
Conclusion
Gregory Hurlbut is making strides in the pharmaceutical field with his innovative approaches to treating cystic fibrosis. His latest patent applications reflect his commitment to addressing critical health issues through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile